Short sellers increased their bets against the broader healthcare sector in February vs. January, and Moderna remained the ...
The S&P 500 is facing one of its most challenging starts to a trading year in history but that doesn't necessarily mean its ...
Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...
Hinge Health files for an IPO, aiming for a NYSE listing under 'HNGE' as revenue jumps 33% to $390M in 2024 and net losses narrow significantly.
11h
Zacks Investment Research on MSNWhy Encompass Health (EHC) is a Top Value Stock for the Long-TermIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results